1. Home
  2. AVTX vs CMU Comparison

AVTX vs CMU Comparison

Compare AVTX & CMU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVTX
  • CMU
  • Stock Information
  • Founded
  • AVTX 2011
  • CMU 1987
  • Country
  • AVTX United States
  • CMU United States
  • Employees
  • AVTX N/A
  • CMU N/A
  • Industry
  • AVTX Biotechnology: Pharmaceutical Preparations
  • CMU Investment Managers
  • Sector
  • AVTX Health Care
  • CMU Finance
  • Exchange
  • AVTX Nasdaq
  • CMU Nasdaq
  • Market Cap
  • AVTX 88.4M
  • CMU 89.6M
  • IPO Year
  • AVTX 2015
  • CMU N/A
  • Fundamental
  • Price
  • AVTX $8.18
  • CMU $3.55
  • Analyst Decision
  • AVTX Strong Buy
  • CMU
  • Analyst Count
  • AVTX 4
  • CMU 0
  • Target Price
  • AVTX $33.00
  • CMU N/A
  • AVG Volume (30 Days)
  • AVTX 64.7K
  • CMU 82.4K
  • Earning Date
  • AVTX 03-28-2025
  • CMU 01-01-0001
  • Dividend Yield
  • AVTX N/A
  • CMU 4.08%
  • EPS Growth
  • AVTX N/A
  • CMU N/A
  • EPS
  • AVTX N/A
  • CMU 0.07
  • Revenue
  • AVTX $820,000.00
  • CMU N/A
  • Revenue This Year
  • AVTX N/A
  • CMU N/A
  • Revenue Next Year
  • AVTX N/A
  • CMU N/A
  • P/E Ratio
  • AVTX N/A
  • CMU $47.57
  • Revenue Growth
  • AVTX N/A
  • CMU N/A
  • 52 Week Low
  • AVTX $4.18
  • CMU $2.78
  • 52 Week High
  • AVTX $34.46
  • CMU $3.38
  • Technical
  • Relative Strength Index (RSI)
  • AVTX 52.50
  • CMU 55.53
  • Support Level
  • AVTX $7.82
  • CMU $3.50
  • Resistance Level
  • AVTX $8.50
  • CMU $3.58
  • Average True Range (ATR)
  • AVTX 0.78
  • CMU 0.02
  • MACD
  • AVTX 0.20
  • CMU 0.01
  • Stochastic Oscillator
  • AVTX 73.11
  • CMU 66.67

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical stage biotechnology company focused on the treatment of immune dysregulation. The company's lead asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).

About CMU MFS Municipal Income Trust

Mfs High Yield Municipal Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to seek high current income exempt from federal income tax. The fund invests a majority of its net assets, including assets attributable to preferred shares and borrowings for investment purposes, in tax-exempt bonds and tax-exempt notes.

Share on Social Networks: